Curaleaf Holdings (CURLF) Long-Term Deferred Tax (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Long-Term Deferred Tax of $443000.0 for Q4 2025, up 10.47% year-on-year from $401000.0 in Q4 2024, and up 10.47% on a QoQ basis from $401000.0 in Q4 2024.
Curaleaf Holdings (CURLF) Long-Term Deferred Tax (2019 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Long-Term Deferred Tax for 7 consecutive years, with $443000.0 the latest figure, recorded in Q4 2025.
- Quarterly Long-Term Deferred Tax rose 10.47% year-over-year to $443000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $443000.0 (up 10.47% YoY) and the FY2025 annual result came in at $443000.0, up 10.47% from the prior year.
- Long-Term Deferred Tax grew to $443000.0 in Q4 2025 per CURLF's latest filing, from $401000.0 in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for CURLF reached as high as $2.7 billion in Q1 2022 and fell as low as $382000.0 in Q3 2021.
- A 5-year average of $180.2 million and a median of $1.6 million in 2022 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2021 — Long-Term Deferred Tax plunged 85.78% — and 2022, when it soared 48290.01%.
- Year by year, Long-Term Deferred Tax stood at $2.2 million in 2021, then decreased by 27.42% to $1.6 million in 2022, then slumped by 73.21% to $419000.0 in 2023, then dropped by 4.3% to $401000.0 in 2024, then climbed by 10.47% to $443000.0 in 2025.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $443000.0, $401000.0, and $594000.0 for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 443,000.00 |
| Dec 31, 2024 | 401,000.00 |
| Sep 30, 2024 | 594,000.00 |
| Jun 30, 2024 | 1.22 Mn |
| Dec 31, 2023 | 419,000.00 |
| Sep 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | 1.29 Mn |
| Dec 31, 2022 | 1.56 Mn |
| Sep 30, 2022 | 3.47 Mn |
| Jun 30, 2022 | 2.98 Mn |
| Mar 31, 2022 | 2.68 Bn |
| Dec 31, 2021 | 2.16 Mn |
| Sep 30, 2021 | 382,000.00 |
| Jun 30, 2021 | 6.27 Mn |
| Mar 31, 2021 | 5.53 Mn |
| Dec 31, 2020 | 5.53 Mn |
| Sep 30, 2020 | 2.69 Mn |
| Dec 31, 2019 | 2.63 Mn |